olmesartan has been researched along with Inflammation in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Bekki, M; Fukumoto, Y; Honda, A; Igata, S; Kurata, S; Maeda-Ogata, S; Matsui, T; Nishino, Y; Sugiyama, Y; Tahara, A; Tahara, N; Yamagishi, SI | 1 |
| Abd El Fattah, MA; Ahmed, KA; Aziz, MM; Sayed, HM | 1 |
| Afzal, M; Al Rikabi, AC; Al-Harbi, MM; Al-Harbi, NO; Al-Shabanah, OA; Alotaibi, MR; As Sobeai, HM; Imam, F; Kazmi, I | 1 |
| Carbone, A; Cicero, AF; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Querci, F | 3 |
| Andreeva, AA | 1 |
| Fincher, K; Mangin, M; Sinha, R | 1 |
| Araújo, TE; Borba, PB; da Silva, AI; de Araújo Júnior, RF; de Araújo, AA; de Souza, FH; Nogueira, AC; Saldanha, TS | 1 |
| Chen, DR; Gao, PJ; Ruan, CC; Yan, C; Zhang, K; Zhang, ZB | 1 |
| Futai, R; Ito, T; Kawanishi, Y; Kitaura, Y; Terasaki, F | 1 |
| Casiglia, E; Corbetti, F; Cuppini, S; Mazza, A; Ravenni, R; Sacco, A; Schiavon, L; Viale, A; Zamboni, S; Zattoni, L | 1 |
| Aki, K; Arai, T; Fujita, E; Fukuda, Y; Fukunaga, Y; Ishikawa, A; Kuwahara, N; Masuda, Y; Mii, A; Natori, Y; Shimizu, A | 1 |
| Gurusamy, N; Kodama, M; Lakshmanan, AP; Ma, M; Nagata, M; Sukumaran, V; Suzuki, K; Takagi, R; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Herman, ML; Kelly, DG; Ludvigsson, JF; Mangan, TF; Murray, JA; Rubio-Tapia, A; Wu, TT | 1 |
| Fischer, JW; Fritzenkötter, C; Li, J; Sandmann, S; Spormann, J; Tiede, K; Unger, T | 1 |
| Egashira, K; Funakoshi, K; Ihara, Y; Nakano, K; Ohtani, K; Sata, M; Sunagawa, K; Zhao, G | 1 |
| Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishio, M; Ohtani, T; Sakata, Y; Takeda, Y; Yamamoto, K; Yoshida, J | 1 |
| Havekes, LM; Jukema, JW; Kleemann, R; Kooistra, T; Princen, HM; van der Hoorn, JW | 1 |
| Imaizumi, T; Inoue, H; Matsui, T; Nakamura, K; Okuda, S; Takeuchi, M; Ueda, S; Yamagishi, S | 1 |
| Fujitani, Y; Hirose, T; Ikeda, F; Kawamori, R; Mita, T; Nakayama, S; Shimizu, T; Uchino, H; Watada, H | 1 |
1 review(s) available for olmesartan and Inflammation
| Article | Year |
|---|---|
Inflammation and vitamin D: the infection connection.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Bacterial Infections; Humans; Imidazoles; Inflammation; Receptors, Calcitriol; Tetrazoles; Vitamin D; Vitamin D Deficiency | 2014 |
5 trial(s) available for olmesartan and Inflammation
| Article | Year |
|---|---|
Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Essential Hypertension; Humans; Hypertension; Inflammation; Middle Aged | 2023 |
Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapies.
Topics: Adipokines; Amlodipine; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Inflammation; Insulin; Insulin Resistance; Interleukin-10; Interleukin-8; Lipids; Male; Middle Aged; Tetrazoles | 2013 |
Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation.
Topics: Amlodipine; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Inflammation; Insulin Resistance; Lipids; Male; Middle Aged; Tetrazoles | 2014 |
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Inflammation; Insulin Resistance; Lipids; Male; Middle Aged; Tetrazoles | 2014 |
Olmesartan ameliorates myocardial function independent of blood pressure control in patients with mild-to-moderate hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Blood Pressure; C-Reactive Protein; Calcium Channel Blockers; Echocardiography, Doppler, Color; Female; Fibrosis; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Male; Middle Aged; Myocardium; Severity of Illness Index; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Function, Left | 2009 |
15 other study(ies) available for olmesartan and Inflammation
| Article | Year |
|---|---|
Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
Topics: Animals; Antioxidants; Apoptosis; Cardiotoxicity; Carnitine; Creatine Kinase, MB Form; Doxorubicin; Heart; Imidazoles; Inflammation; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardium; Oxidative Stress; Protective Agents; Rats; Tetrazoles; Troponin I; Tumor Necrosis Factor-alpha | 2020 |
Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway.
Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Flavonoids; Imidazoles; Inflammation; Kidney; Male; NF-kappa B; Nitric Oxide Synthase; Oligopeptides; Oxidative Stress; Rats; Rats, Wistar; Rutin; Signal Transduction; Tetrazoles | 2019 |
[Dynamics the level of visfatin and markers of immune inflammation in hypertensive patients with abdominal obesity using the combination of antihypertensive therapy].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Humans; Imidazoles; Immune System Diseases; Inflammation; Interleukin-4; Lipid Metabolism; Nicotinamide Phosphoribosyltransferase; Obesity, Abdominal; Tetrazoles | 2013 |
In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Diarrhea; Disease Models, Animal; Imidazoles; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestine, Small; Male; Methotrexate; Mucositis; Neoplasms; Olmesartan Medoxomil; Rats, Wistar; Sucrose; Tetrazoles; Tumor Necrosis Factor-alpha; Weight Loss | 2015 |
Activating transcription factor 3 SUMOylation is involved in angiotensin II-induced endothelial cell inflammation and dysfunction.
Topics: Activating Transcription Factor 3; Angiotensin II; Animals; Aorta; Endothelial Cells; Gene Expression Regulation; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Inflammation; Interleukin-6; Mice; Nitric Oxide; Receptor, Angiotensin, Type 1; SUMO-1 Protein; Sumoylation; Tetrazoles; Vasodilation | 2016 |
Does treatment with olmesartan improve arterial stenoses due to fibromuscular dysplasia?
Topics: Angiotensin II Type 1 Receptor Blockers; Biomarkers; Carotid Stenosis; Female; Fibromuscular Dysplasia; Humans; Image Processing, Computer-Assisted; Imidazoles; Inflammation; Middle Aged; Reactive Oxygen Species; Tetrazoles; Tomography, X-Ray Computed; Ultrasonography | 2009 |
ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Anti-Glomerular Basement Membrane Disease; Blood Pressure; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Imidazoles; Inflammation; Kidney Glomerulus; Macrophages; Male; Rats; Rats, Inbred WKY; Tetrazoles | 2010 |
Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Autoimmune Diseases; Cardiotonic Agents; Endoplasmic Reticulum Stress; Heart Failure; Imidazoles; Inflammation; JNK Mitogen-Activated Protein Kinases; Membrane Glycoproteins; Myocarditis; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Phosphoproteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Receptors, Interleukin-1; RNA, Messenger; Tetrazoles | 2012 |
Severe spruelike enteropathy associated with olmesartan.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Anemia; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Colitis, Microscopic; Collagen; Diarrhea; Fatigue; Female; Gastritis; Hospitalization; Humans; Hypoalbuminemia; Imidazoles; Inflammation; Intestinal Mucosa; Intestines; Lymphocytes; Male; Middle Aged; Nausea; Severity of Illness Index; Stomach; Tetrazoles; Vomiting; Water-Electrolyte Imbalance; Weight Loss; Zinc | 2012 |
Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Cardiovascular System; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Inflammation; Interleukin-1; Interleukin-6; Male; Myocardial Infarction; Placebos; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Biomarkers; Blood Pressure; Blood Vessels; Cell Differentiation; Constriction, Pathologic; Iliac Artery; Imidazoles; Inflammation; Inflammation Mediators; Isoenzymes; Macaca fascicularis; Male; Monocytes; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Rabbits; Recurrence; Renin-Angiotensin System; Stem Cells; Stents; Tetrazoles; Tunica Intima; Valine; Valsartan | 2006 |
Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Chemokine CCL2; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Male; NADPH Oxidases; Oxidative Stress; Random Allocation; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Tetrazoles; Transforming Growth Factor beta1; Ventricular Remodeling | 2007 |
Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoprotein E3; Atherosclerosis; Blood Pressure; Collagen; Diet, Atherogenic; Drug Synergism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Inflammation; Lipids; Macrophages; Mice; Mice, Transgenic; Monocytes; Muscle, Smooth, Vascular; Pravastatin; Recombinant Proteins; Serum Amyloid A Protein; T-Lymphocytes; Tetrazoles | 2007 |
Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species.
Topics: Angiotensin II Type 1 Receptor Blockers; Cell Adhesion; Cells, Cultured; Chemokine CCL2; Endothelial Cells; Glycation End Products, Advanced; Humans; Imidazoles; Inflammation; Intercellular Adhesion Molecule-1; Reactive Oxygen Species; Serum Albumin, Bovine; T-Lymphocytes; Tetrazoles | 2008 |
Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Inflammation; Japan; Male; Metabolic Syndrome; Middle Aged; Telmisartan; Tetrazoles | 2008 |